About Us

Mission Statement

The Chinese Bioscience Association (CBA) is a non-profit organization founded in the San Francisco Bay area in 1997. Its mission is to promote education, networking and community building for life science professionals. Since its foundation, CBA has held hundreds of scientific conferences and workshops focusing on emerging trends and cutting-edge technologies in the biotech industry and attracted participants from entrepreneurs, C-level executives, managers, scientists, post-docs and students.

CBA currently has hundreds of active members and supporters ranging from CEOs, founders, business executives, professors, mid-level managers, scientists, students and postdocs. As a bi-lingual non-profit organization, CBA plays a key role to bridge the industry and cultural gaps between US and Asia, and has strong ties to Taiwan, China (including Hong Kong) and Singapore. Our annual conferences and summer picnics are especially popular with members, friends and family members. CBA is a volunteer organization supported generously by its sponsors and members.

A Message from our President – Xinguo Jiang:

It is an honor and a great source of enthusiasm to serve as the President of the Chinese Bioscience Association (CBA) for the year 2023. Since its establishment in 1997, CBA has grown significantly, attracting more than a thousand members and establishing a vibrant professional community where individuals with backgrounds in bioscience and related fields can come together to exchange ideas. Over the past two decades, the field of biological science has witnessed transformative advancements, largely due to the emergence of new technologies such as high-speed sequencing, multi-omics, and machine learning. These developments have significantly contributed to our understanding of biology and expedited the discovery of new targets for the development of more effective treatments for both acute and chronic diseases, including age-related illnesses.

The rise of artificial intelligence (AI), exemplified by ChatGPT, has already had a profound impact on various aspects of our lives. Understanding how similar technologies may influence biomedical research and the biotech industry has become a pressing topic for professionals in our field.

To enhance our awareness of AI in biomedicine, CBA will be organizing a series of seminars and activities designed to help our members adapt to this unique era. The centerpiece of our efforts is the annual conference, which consistently attracts several hundred attendees. This year, the conference will focus on the theme of big data and AI in precision medicine, with a particular emphasis on aging and other frontiers in biomedical science and technology. We are delighted to announce that our lineup of speakers for the conference includes esteemed experts such as Dr. Michael Snyder, Chair of Genetics and Director of Genomics and Personalized Medicine at Stanford University, who is globally recognized as a leader in the field. Additionally, we will be joined by Dr. Carolyn Bertozzi, the 2022 Nobel Prize laureate for her groundbreaking work on Click Chemistry and a renowned expert in glycobiology from Stanford University. Another distinguished speaker will be Dr. Juan Carlos Izpisua Belmonte, Director of the San Diego Institute of Science of Altos Labs, who is a leading scientific innovator in cellular reprogramming and aging. Furthermore, the conference will feature sessions dedicated to entrepreneurship and investment.

We extend a warm invitation to you to attend our annual conference. It promises to be an excellent opportunity to gain insights into the latest advances from esteemed experts and network with leaders in academia and industry.

Lastly, I would like to express my gratitude to all our sponsors, volunteers, and members for their unwavering support. It is through your contributions and participation that CBA’s seminars and activities have been made possible. I eagerly anticipate your presence at future events organized by CBA.

Sincerely yours,

Xinguo Jiang MD, PhD

CBA President (2023)